Hinge Health

HNGE

Market cap $3.53B

The cost of healthcare in the United States is on the rise in a big way. In its 2026 healthcare outlook, the Big Four accounting firm PricewaterhouseCoopers (PwC) made strong statements confirming this reality.

The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Hinge Health is using artificial intelligence to keep physical therapy costs down for employers. The company improved revenue by 51% in 2025.

Hinge Health combines robust 2025 growth (51% revenue, 31% FCF margin) with best-in-class digital MSK therapy, serving 24.6M covered lives. HNGE trades at 12–14x 2026 FCF, with management guiding 25% revenue growth but strong signals this is conservative. Defensibility against AI disruption is high due to healthcare barriers, proprietary data, hardware integration, and clinical outcomes, supporting a durable moat.

Hinge Health beat on top and bottom lines last night. Hinge is growing sales, earnings, and free cash flow rapidly, though growth could slow in 2026.

Hinge Health Inc. (NYSE: HNGE) stock rose Wednesday after the company reported better-than-expected fourth-quarter earnings.

Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025. “We closed out the year with an exceptional quarter and a strong selling season, driving our highest win rates to date and greatest number of eligible lives added in any year,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “Our commercial momentum, combined with expanding margins and strong cash generation, gives us confidence in our a.

SAN FRANCISCO--(BUSINESS WIRE)--Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today's fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges and opportunities for industry-wide improvements. The dual-perspective survey – along with real patient and provider sto.

Hinge Health Inc. (HNGE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.